Early-life heterologous rhinovirus infections induce an exaggerated asthma-like phenotype

Charu Rajput1, Mingyuan Han1, Tomoko Ishikawa1

  • 1Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Mich.

Abstract

Insights

Early rhinovirus (RV) infection in infants primes the immune system, leading to an exaggerated asthma-like response upon subsequent infections. This heightened allergic reaction is dependent on type 2 innate lymphoid cells (ILC2s).

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Pediatrics

Background:

  • Early-life respiratory tract infections, particularly by rhinovirus (RV), are significant risk factors for asthma development.
  • Infants are frequently exposed to diverse RV strains annually, increasing susceptibility.
  • Previous research linked RV infection in young mice to mucous metaplasia, a process mediated by type 2 innate lymphoid cells (ILC2s).

Purpose of the Study:

  • To investigate whether early-life RV infection modifies the immune response to subsequent, different RV infections.
  • To determine if this altered response leads to an exaggerated asthma-like phenotype.
  • To elucidate the role of ILC2s in mediating these changes.

Main Methods:

  • BALB/c mice (wild-type and ILC2-deficient Rorafl/flIl7rcre) were subjected to sequential infections with different RV strains (RV-A1B and RV-A2) or sham treatments at specific early-life time points.
  • Mice received either sham or RV-A1B on day 6, followed by sham or RV-A2 on day 13.
  • Immune responses, including bronchoalveolar lavage eosinophils, cytokine mRNA expression (IL-13, IFN-γ), mucus production markers (Gob5, Muc5b, Muc5ac), and airway hyperresponsiveness, were assessed.

Main Results:

  • Single RV-A1B infection in early life induced a type 2 immune response (increased IL-13), while RV-A2 induced a type 1 response (increased IFN-γ).
  • Sequential infection (RV-A1B followed by RV-A2) resulted in significantly amplified type 2 responses, characterized by elevated IL-13, IL-5, mucus production, eosinophils, and ILC2s.
  • This sequential infection led to exaggerated mucus metaplasia and airway hyperresponsiveness, mimicking asthma.
  • ILC2-deficient mice showed a complete absence of these exaggerated responses, confirming ILC2 dependence.

Conclusions:

  • Early-life RV infection profoundly alters the immune system's response to subsequent heterologous infections.
  • This alteration results in an intensified, asthma-like phenotype.
  • The development of this exaggerated phenotype is critically dependent on the presence and function of ILC2s.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
808
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K